Two former executives who sold millions of dollars in faulty sterilization devices that have been blamed for leaving 18 patients blind in one eye have been sentenced to prison time.
A former HealthSouth Corp. chief financial officer was sentenced to three years in prison Tuesday just as news hit that his former employer would pay $17 million in legal bills for Richard Scrushy, the company’s former chief executive officer.
Troubled media tycoon Conrad Black on Friday pled not guilty in U.S. federal court to another pile of charges related to federal investigations into his alleged misappropriations of his former newspaper empire.
Accounting firm KPMG LLP may still have to foot the legal bills for sixteen former executives implicated in the tax-shelter scandal, after a judge refused to dismiss the suit they filed against the company.
It will be about a year before a jury will hear the case of three former bankers whose extradition from the United Kingdom to face Enron-related charges in the United States caused a stir in the U.S. and abroad.
Despite a last-ditch effort to avoid prosecution, transport company Stolt-Nielsen SA has been indicted by the Department of Justice for its role in a bid-rigging scheme in the global carrier industry.
Despite a pledge from the zealous Japanese businessman who launched Internet firm Livedoor Co. that he did not violate securities laws, a prosecution witness painted a different picture Tuesday, testifying that Livedoor manipulated its earnings by selling and buying company shares.
A former Enron executive who pled guilty to federal charges of improperly recognizing revenue has asked a court if he can take it back.
The first two former executives to face criminal charges in the stock-option backdating scandal pled not guilty Wednesday, but they likely won’t go to trial for nearly a year.
A Canadian court has frozen the assets of Conrad Black and his wife, Barbara Amiel Black, forcing the former media mogul and his socialite wife to make do with a lackluster allowance of $20,000 a month, according to a source familiar with the court order.
The U.S. Justice Department announced Tuesday that Schering-Plough Corp. will pay $435 million to settle charges of Medicaid fraud and improper marketing of drugs.
As the options backdating scandal continues to widen, regulators and shareholders may soon set their sights on a new target: the attorneys and auditors consulted in the development and execution of executive stock options plans.
After months of escaping the law, a former employee of agrochemical giant Dow Chemical Co. has been arrested in Seattle on charges that he stole company trade secrets in order to market them to Chinese businesses.
One of four attorneys on the legal team prosecuting former Enron Corp. executives has been named lead prosecutor in the insider-trading case against Joseph Nacchio, the former chief executive officer of Qwest Communications International Inc.
Former technology banking star Frank Quattrone proved himself bullet-proof on Tuesday when a U.S. federal court judge approved a settlement that would not only let him avoid a third trial on obstruction-of-justice charges, but also possibly usher him back into a career on Wall Street.
Eight individuals and six companies are facing charges stemming from their alleged roles in a $70 million dollar black-market prescription drug ring.
A grand jury has added new charges to the stack of allegations against embattled media mogul Conrad Black and three co-defendants, claiming their fraudulent scheme led Hollinger International Inc. to file inaccurate income tax returns.
A Massachusetts hedge fund advisor is facing 13 counts of mail and wire fraud after prosecutors alleged he lied to investors about the fund’s investment strategy and then falsified documents to cover up his fabrications.
The estate of Ken Lay asked a judge Wednesday to clear the late Enron founder’s name, but government prosecutors said they would not give up the fight for $43.5 million in allegedly ill-gotten gains.
Regulators are taking a closer look at transactions between the reinsurance arm of Berkshire Hathaway Inc. and two other reinsurance providers, as part of an ongoing probe into allegations of improper reinsurance accounting.